neostigmine has been researched along with Pheochromocytoma, Extra-Adrenal in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thurtle, OA | 1 |
| Allen, AP | 1 |
| Walters, MT | 1 |
| Kitchen, JV | 1 |
| Smith, CL | 1 |
| Cawley, MI | 1 |
| James, TN | 1 |
2 other studies available for neostigmine and Pheochromocytoma, Extra-Adrenal
| Article | Year |
|---|---|
Intractable constipation in malignant phaeochromocytoma: combined treatment with adrenergic blockade and cholinergic drugs.
Topics: Constipation; Female; Humans; Middle Aged; Neostigmine; Phentolamine; Pheochromocytoma | 1984 |
Small arteries of the heart.
Topics: Acetylcholine; Amyloidosis; Animals; Arterial Occlusive Diseases; Arteries; Cardiomegaly; Coronary V | 1977 |